Country Trust Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.1M | Buy |
90,136
+312
| +0.3% | +$139K | 0.9% | 37 |
|
2025
Q1 | $43.5M | Buy |
89,824
+6,222
| +7% | +$3.02M | 1.1% | 28 |
|
2024
Q4 | $33.7M | Sell |
83,602
-10,489
| -11% | -$4.22M | 0.84% | 42 |
|
2024
Q3 | $43.8M | Sell |
94,091
-250
| -0.3% | -$116K | 1.07% | 30 |
|
2024
Q2 | $44.2M | Buy |
94,341
+16
| +0% | +$7.5K | 1.12% | 26 |
|
2024
Q1 | $39.4M | Sell |
94,325
-7,859
| -8% | -$3.29M | 1.02% | 32 |
|
2023
Q4 | $41.6M | Sell |
102,184
-17,605
| -15% | -$7.16M | 1.16% | 30 |
|
2023
Q3 | $41.7M | Sell |
119,789
-13,477
| -10% | -$4.69M | 1.22% | 23 |
|
2023
Q2 | $46.9M | Sell |
133,266
-4,435
| -3% | -$1.56M | 1.27% | 24 |
|
2023
Q1 | $43.4M | Sell |
137,701
-9,722
| -7% | -$3.06M | 1.23% | 26 |
|
2022
Q4 | $42.6M | Sell |
147,423
-940
| -0.6% | -$271K | 1.26% | 27 |
|
2022
Q3 | $43M | Buy |
148,363
+17,752
| +14% | +$5.14M | 1.35% | 22 |
|
2022
Q2 | $36.8M | Sell |
130,611
-7,027
| -5% | -$1.98M | 1.16% | 31 |
|
2022
Q1 | $35.9M | Sell |
137,638
-42,030
| -23% | -$11M | 1% | 39 |
|
2021
Q4 | $39.5M | Buy |
179,668
+19,269
| +12% | +$4.23M | 1.07% | 32 |
|
2021
Q3 | $29.1M | Buy |
160,399
+65,631
| +69% | +$11.9M | 0.85% | 49 |
|
2021
Q2 | $19.1M | Buy |
94,768
+94,588
| +52,549% | +$19.1M | 0.57% | 65 |
|
2021
Q1 | $39K | Hold |
180
| – | – | ﹤0.01% | 215 |
|
2020
Q4 | $43K | Buy |
+180
| New | +$43K | ﹤0.01% | 191 |
|
2019
Q1 | – | Sell |
-14
| Closed | -$2K | – | 336 |
|
2018
Q4 | $2K | Buy |
14
+6
| +75% | +$857 | ﹤0.01% | 292 |
|
2018
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 302 |
|
2018
Q2 | $1K | Sell |
8
-30
| -79% | -$3.75K | ﹤0.01% | 300 |
|
2018
Q1 | $6K | Buy |
+38
| New | +$6K | ﹤0.01% | 244 |
|